NCT03929484

A Feasibility Study Evaluating a Novel Mask (Nasal Reservoir Cannula)

Terminated NA Last updated 26 April 2019

What this trial tests

NA trial testing Nasal reservoir cannula in Pneumonia Childhood in 8 participants. Terminated before completion.

Timeline

1 September 2017

Primary endpoint
31 March 2018

31 March 2018

Quick facts

Lead sponsor	University of California, San Francisco
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	device feasibility
Enrollment	8
Start date	1 September 2017
Primary completion	31 March 2018
Estimated completion	31 March 2018
Sites	1 location across Uganda

Drugs / interventions tested

• Nasal reservoir cannula

Conditions studied

• Pneumonia Childhood — all drugs for Pneumonia Childhood →

Sponsor

University of California, San Francisco

Who can join

Adults 1 to 6, any sex, with Pneumonia Childhood. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the addition of a novel mask (nasal reservoir cannula) to a standard nasal cannula during supplemental oxygenation for the treatment of hospitalized pediatric patients with hypoxemia due to severe pneumonia. Half of patients (Group A) will receive oxygen for 1 hour using a novel mask (nasal reservoir cannula) plus standard nasal cannula (Period 1), followed by a 1-hour period of continued use of the standard nasal cannula delivery (Period 2). Half of patients (Group B) will receive oxygen for 1 hour using a standard nasal cannula (Period 1), followed by a 1-hour period of continued use of the novel mask (nasal reservoir cannula) plus standard nasal cannula (Period 2).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.